Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

AIMS : The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Harvey D, Steg, Ph Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Erglis, Andrejs, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lopes, Renato D, Mahaffey, Kenneth W, Moryusef, Angele, Pordy, Robert, Roe, Matthew T, Sritara, Piyamitr, Tricoci, Pierluigi, Zeiher, Andreas M, Schwartz, Gregory G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736383/
https://www.ncbi.nlm.nih.gov/pubmed/31121022
http://dx.doi.org/10.1093/eurheartj/ehz299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736383/
https://www.ncbi.nlm.nih.gov/pubmed/31121022
http://dx.doi.org/10.1093/eurheartj/ehz299

Ejemplares similares